{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T02:36:29Z","timestamp":1767926189279,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T00:00:00Z","timestamp":1455494400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s10120-016-0598-0","type":"journal-article","created":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T05:32:44Z","timestamp":1455514364000},"page":"190-199","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Feasibility of weekly intraperitoneal versus intravenous paclitaxel therapy delivered from the day of radical surgery for gastric cancer: a preliminary safety analysis of the INPACT study, a randomized controlled trial"],"prefix":"10.1007","volume":"20","author":[{"given":"Yasuhiro","family":"Kodera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Takiguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumasa","family":"Fujitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsufumi","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Imano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,15]]},"reference":[{"key":"598_CR1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359\u201386.","journal-title":"Int J Cancer"},{"key":"598_CR2","first-page":"3","volume":"75","author":"Y Kodera","year":"2013","unstructured":"Kodera Y. Gastric cancer with minimal peritoneal metastasis: is this a sign to give up or to treat more aggressively? Nagoya J Med Sci. 2013;75:3\u201310.","journal-title":"Nagoya J Med Sci"},{"key":"598_CR3","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1007\/s00268-015-3144-z","volume":"39","author":"Y Miki","year":"2015","unstructured":"Miki Y, Tokunaga M, Tanizawa Y, Bando E, Kawamura T, Terashima M. Staging laparoscopy for patients with cM0, type 4 and large type 3 gastric cancer. World J Surg. 2015;39:2742\u20137.","journal-title":"World J Surg"},{"key":"598_CR4","first-page":"960","volume":"54","author":"Y Kodera","year":"2007","unstructured":"Kodera Y, Ito Y, Ito S, Ohashi N, Mochizuki Y, Yamamura Y, et al. Intraperitoneal paclitaxel: a possible impact of regional delivery for prevention of peritoneal carcinomatosis in patients with gastric carcinoma. Hepatogastroenterology. 2007;54:960\u20133.","journal-title":"Hepatogastroenterology"},{"key":"598_CR5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000209277","volume":"76","author":"H Ishigami","year":"2009","unstructured":"Ishigami H, Kitayama J, Otani K, Kamei T, Soma D, Moyato H, et al. Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer. Oncology. 2009;76:311\u20134.","journal-title":"Oncology."},{"key":"598_CR6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/annonc\/mdp260","volume":"21","author":"H Ishigami","year":"2010","unstructured":"Ishigami H, Kitayama J, Kaisaki S, Hidemura A, Kato M, Otani K, et al. Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. Ann Oncol. 2010;21:67\u201370.","journal-title":"Ann Oncol"},{"key":"598_CR7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med. 2006;354:34\u201343.","journal-title":"N Engl J Med"},{"key":"598_CR8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s10120-011-0027-3","volume":"14","author":"I Miyashiro","year":"2011","unstructured":"Miyashiro I, Furukawa H, Sasako M, Yamamoto S, Nashimoto A, Nakajima T, et al. Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2. Gastric Cancer. 2011;14:212\u20138.","journal-title":"Gastric Cancer"},{"key":"598_CR9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/CAD.0000000000000179","volume":"26","author":"M Vita Di","year":"2015","unstructured":"Di Vita M, Cappellani A, Piccolo G, Zanghi A, Cavallaro A, Bertola G, et al. The role of HIPEC in the treatment of peritoneal carcinomatosis from gastric cancer: between lights and shadows. Anticancer Drugs. 2015;26:123\u201338.","journal-title":"Anticancer Drugs"},{"key":"598_CR10","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","volume":"357","author":"S Sakuramoto","year":"2007","unstructured":"Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810\u201320.","journal-title":"N Engl J Med"},{"key":"598_CR11","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.ejso.2009.03.003","volume":"35","author":"Y Kodera","year":"2009","unstructured":"Kodera Y, Ito S, Mochizuki Y, Kondo K, Koshikawa K, Suzuki N, et al. A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study). Eur J Surg Oncol. 2009;35:1158\u201363.","journal-title":"Eur J Surg Oncol"},{"key":"598_CR12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1470-2045(08)70035-4","volume":"9","author":"W Koizumi","year":"2008","unstructured":"Koizumi W, Narahara H, Hara T, Takagane A, Akiya T, Takagi M, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008;9:215\u201321.","journal-title":"Lancet Oncol."},{"key":"598_CR13","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s10120-014-0384-9","volume":"18","author":"K Kurimoto","year":"2015","unstructured":"Kurimoto K, Ishigure K, Mochizuki Y, Ishiyama A, Matsui T, Ito S, et al. A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for stage III\/IV gastric cancer (CCOG1106). Gastric Cancer. 2015;18:354\u20139.","journal-title":"Gastric Cancer"},{"key":"598_CR14","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jjco\/hyq187","volume":"41","author":"Y Kodera","year":"2011","unstructured":"Kodera Y, Imano M, Yoshikawa T, Takahashi N, Ysuburaya A, Miyashita Y, et al. A randomized phase II trial to test the efficacy of intra-peritoneal paclitaxel for gastric cancer with high risk for the peritoneal metastasis (INPACT trial). Jpn J Clin Oncol. 2011;41:283\u20136.","journal-title":"Jpn J Clin Oncol"},{"key":"598_CR15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/jso.23301","volume":"107","author":"Y Iwasaki","year":"2013","unstructured":"Iwasaki Y, Sasako M, Yamamoto S, Nakamura K, Sano T, Katai H, et al. Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210). J Surg Oncol. 2013;107:741\u20135.","journal-title":"J Surg Oncol"},{"key":"598_CR16","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1200\/JCO.2005.05.2456","volume":"24","author":"M Markman","year":"2006","unstructured":"Markman M, Walker JL. Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment. J Clin Oncol. 2006;24:988\u201394.","journal-title":"J Clin Oncol"},{"key":"598_CR17","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1200\/JCO.1995.13.12.2961","volume":"13","author":"P Francis","year":"1995","unstructured":"Francis P, Rowinsky E, Schneider J, Hales T, Hoskins W, Markman M. Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot study. J Clin Oncol. 1995;13:2961\u20137.","journal-title":"J Clin Oncol"},{"key":"598_CR18","first-page":"2667","volume":"27","author":"Y Kodera","year":"2007","unstructured":"Kodera Y, Ito S, Mochizuki Y, Fujitake S, Koshikawa K, Kanyama Y, et al. A phase II study of weekly paclitaxel as second-line chemotherapy for advanced gastric cancer (CCOG0302 study). Anticancer Res. 2007;27:2667\u201371.","journal-title":"Anticancer Res"},{"key":"598_CR19","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s10120-006-0364-9","volume":"9","author":"M Kobayashi","year":"2006","unstructured":"Kobayashi M, Tsuburaya A, Nagata N, Miyashita Y, Oba K, Sakamoto J. A feasibility study of sequential paclitaxel and S-1 (PTX\/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer. Gastric Cancer. 2006;9:114\u20139.","journal-title":"Gastric Cancer"},{"key":"598_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","volume":"10","author":"R Simon","year":"1989","unstructured":"Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials. 1989;10:1\u201310.","journal-title":"Control Clin Trials"},{"key":"598_CR21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2168.2000.01358.x","volume":"87","author":"Y Maehara","year":"2000","unstructured":"Maehara Y, Hasuda S, Koga T, Tokunaga E, Kakeji Y, Sugimachi K. Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg. 2000;87:353\u20137.","journal-title":"Br J Surg"},{"key":"598_CR22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1365-2168.2000.01360.x","volume":"87","author":"C Yoo","year":"2000","unstructured":"Yoo C, Noh S, Shin D, Choi SH, Min JS. Recurrence following curative resection for gastric carcinoma. Br J Surg. 2000;87:236\u201342.","journal-title":"Br J Surg"},{"key":"598_CR23","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.jamcollsurg.2014.03.062","volume":"219","author":"G Spolverato","year":"2014","unstructured":"Spolverato G, Ejaz A, Kim Y, Squires MH, Poultsides GA, Fields RC, et al. Rates and patterns of recurrence after curative intent resection for gastric cancer: a United States multi-institutional analysis. J Am Coll Surg. 2014;219:664\u201375.","journal-title":"J Am Coll Surg"},{"key":"598_CR24","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/SLA.0b013e3181b0c80e","volume":"250","author":"M Kuramoto","year":"2009","unstructured":"Kuramoto M, Shimada S, Ikeshima S, Matsuo A, Yagi Y, Matsuda M, et al. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg. 2009;250:242\u20136.","journal-title":"Ann Surg."},{"key":"598_CR25","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.ejso.2013.10.010","volume":"39","author":"F Roviello","year":"2013","unstructured":"Roviello F, Caruso S, Neri A, Marrelli D. Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: overview and rationale. Eur J Surg Oncol. 2013;39:1309\u201316.","journal-title":"Eur J Surg Oncol"},{"key":"598_CR26","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3748\/wjg.v12.i9.1412","volume":"12","author":"M Kobayashi","year":"2006","unstructured":"Kobayashi M, Sakamoto J, Namikawa T, Okamoto K, Okabayashi T, Ichikawa K, et al. Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients. World J Gastroenterol. 2006;12:1412\u20135.","journal-title":"World J Gastroenterol"},{"key":"598_CR27","doi-asserted-by":"publisher","unstructured":"Nishina T, Boku N, Gotoh M, Shimada Y, Hamamoto Y, Yasui H, et al. Randomized phase II study of second-line chemotherapy with best available 5-fluorouracil versus weekly paclitaxel in far advanced gastric cancer with severe peritoneal metastases refractory to 5-fluorouracil-containing regimens (JCOG0407). Gastric Cancer. 2015. doi: 10.1007\/s10120-015-0542-8 .","DOI":"10.1007\/s10120-015-0542-8"},{"key":"598_CR28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/gyno.1993.1038","volume":"48","author":"RA Senga","year":"1993","unstructured":"Senga RA, Dottino PR, Jennings TS, Cohen CJ. Fesibility of intraoperative administration of chemotherapy for gynecologic malignancies: assessment of acute postoperative morbidity. Gynecol Oncol. 1993;48:227\u201331.","journal-title":"Gynecol Oncol"},{"key":"598_CR29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jso.22065","volume":"105","author":"M Imano","year":"2012","unstructured":"Imano M, Imamoto H, Itoh T, Satou T, Peng YF, Yasuda A, et al. Safety of intraperitoneal administration of paclitaxel after gastrectomy with en-bloc D2 lymph node dissection. J Surg Oncol. 2012;105:43\u20137.","journal-title":"J Surg Oncol"},{"key":"598_CR30","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S1470-2045(14)70025-7","volume":"15","author":"A Tsuburaya","year":"2014","unstructured":"Tsuburaya A, Yoshida K, Kobayashi M, Yoshino S, Takahashi M, Takiguchi N, et al. Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a\/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trial. Lancet Oncol. 2014;15:886\u201393.","journal-title":"Lancet Oncol."}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-016-0598-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10120-016-0598-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-016-0598-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-016-0598-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:22:27Z","timestamp":1559110947000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10120-016-0598-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,15]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["598"],"URL":"https:\/\/doi.org\/10.1007\/s10120-016-0598-0","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,15]]}}}